O'Connor M F, Daves S M, Tung A, Cook R I, Thisted R, Apfelbaum J
Department of Anesthesia and Critical Care, The University of Chicago, Illinois, USA.
Anesthesiology. 2001 Mar;94(3):520-2. doi: 10.1097/00000542-200103000-00025.
Unexpected awareness is a rare but well-described complication of general anesthesia that has received increased scientific and media attention in the past few years. Transformed electroencephalogram monitors, such as the Bispectral Index monitor, have been advocated as tools to prevent unexpected recall.
The authors conducted a power analysis to estimate how many patients would be needed in an appropriately powered study to demonstrate the Bispectral Index monitor reduces awareness, as well as a cost analysis to assess the cost of using the monitor for this purpose alone.
If unexpected recall is rare (1 in 20,000), it will require a large study to demonstrate that the monitor reduces awareness (200,000-800,000 patients), and the cost of using it for this purpose alone would be high ($400,000 per case prevented). If awareness is common (1 in 100), then the number of patients needed in a study to demonstrate that the monitor works becomes tractable (1,000-4,000 patients), and the cost of using the monitor for this purpose alone becomes lower ($2,000 per case prevented). Because there are reported cases of awareness despite Bispectral Index monitoring, the authors are certain that the effectiveness of the monitor is less than 100%. As the performance of the monitor decreases from 100%, the size of the study needed to demonstrate that it works increases, as does the cost of using it to prevent awareness.
The contention that Bispectral Index monitoring reduces the risk of awareness is unproven, and the cost of using it for this indication is currently unknown.
术中知晓是全身麻醉一种罕见但已被充分描述的并发症,在过去几年中受到了科学界和媒体越来越多的关注。双谱指数监测仪等经转换的脑电图监测仪已被倡导作为预防术中知晓的工具。
作者进行了一项效能分析,以估计在一项效能适当的研究中需要多少患者来证明双谱指数监测仪可降低术中知晓的发生率,还进行了一项成本分析,以评估仅为此目的使用该监测仪的成本。
如果术中知晓罕见(20000例中有1例),则需要进行大规模研究才能证明该监测仪可降低术中知晓的发生率(200000 - 800000例患者),且仅为此目的使用该监测仪的成本会很高(每预防一例花费400000美元)。如果术中知晓常见(100例中有1例),那么在一项研究中证明该监测仪有效的所需患者数量变得易于处理(1000 - 4000例患者),且仅为此目的使用该监测仪的成本会降低(每预防一例花费2000美元)。由于有报道称尽管使用了双谱指数监测仍有术中知晓的病例,作者确定该监测仪的有效性小于100%。随着该监测仪的性能从100%下降,证明其有效的所需研究规模会增加,使用它预防术中知晓的成本也会增加。
双谱指数监测可降低术中知晓风险这一论点尚未得到证实,目前其用于该适应症的成本尚不清楚。